Sergey Sulima

Bristol Myers Squibb

Sergey obtained a PhD in molecular and cell biology at the University of Maryland (USA) in 2013, and afterwards carried out post-doctoral research in oncology and hematology at the University of Leuven (Belgium) until 2018. His scientific bibliography includes authorship on 16 publications in leading journals such as Cancer Discovery, Leukemia, Nature, and Nucleic Acids Research. Between 2018 and 2022, Sergey was first a scientific and medical writer at BioNTech (Mainz, Germany), and then a scientific writer and publications manager at the Institute for Biological and Medical Imaging at the Helmholtz Center in Munich, Germany. As of January 2022, Sergey is employed as a senior manager in medical communications at Bristol Myers Squibb in Munich, where he is the publications lead for Germany covering the company’s clinical pipeline (oncology/hematology, immunology, neurology, and cardiovascular diseases). He is a member of the International Society for Medical Publication Professionals (ISMPP) and holds their Certified Medical Publication Professional (CMPP™) credential. Sergey joined EMWA in 2018, has been a workshop leader since 2020, and became member of the EMWA EPDC in 2023